ATEN BIOTECH PRIVATE LIMITED

Aten Porus Lifesciences (APL) is an innovation driven company focused on the development of therapeutics for diseases with a high unmet medical need.

We are disease agnostic with a focus on chemistry oriented solutions for the most pressing medical problems. As a team of chemists, chemical biologists and biologists, we collaborate with some of the leading experts in disease biology to design groundbreaking medicines.

Design and Synthesis of Drug or Prodrug Claims.

Formulation of Drug or Prodrug Claims.

Method of Administration and Treatment Claims.

Founder And Chief Executive Officer

Arun is the Founder and CEO at Aten Porus Lifesciences. He previously co-founded Avammune Therapeutics and Oraxion Therapeutics, R&D companies focused on drug discovery. Arun was instrumental in the option agreement of Oraxion’s technology platform to a US based biotech company for $125 MM.

Arun holds an MBA from the Royal Melbourne Institute of Technology (Australia), and a Bachelor of Science degree from Christ University (India). Arun has over 10 years of experience as an entrepreneur in various aspects of business including Finance, Operations, Technology transfer and Business development.

Founder And Chief Scientific Officer

Aditya is the Founder and CSO at Aten Porus Lifesciences. He previously co-founded Avammune Therapeutics and Oraxion Therapeutics, R&D companies focused on drug discovery. Aditya is the inventor of Oraxion’s technology platform that was eventually licensed to a US based biotech company for $125 MM. He has co-authored >15 papers and filed several international patents in the areas of nucleic acid delivery, Niemann-Pick Type C therapeutics, and drug discovery.

He has been a recipient of scholarships during his Masters and PhD and was also awarded the H. C. Brown Award for Outstanding Organic Research at Purdue University in June 2012. Aditya has a PhD in Bioorganic Chemistry from Purdue University (USA), MS in Chemical Biology from Leeds University (UK), and B.Sc in Chemistry from Christ University (India).

Founder And Director

Srinivasan is the Founder and Director at Aten Porus Lifesciences. He previously co-founded Avammune Therapeutics and Oraxion Therapeutics, both R&D companies focusesd on drug discovery. He is currently serving as the CEO of Porus Labs, a chemical manufacturing conglomerate serving customers across India, US, and Europe.

Srinivasan has over 15 years of experience in varied aspects of business including technology transfer, SCM, Business Development and Finance. Srinivasan has an MS in Pharmaceutics from Northeastern University (USA), and B.Pharm from BITS Pilani (India).